{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:21:16Z","timestamp":1792315276578,"version":"4.4.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[1999,9]]},"DOI":"10.1007\/s10434-999-0562-x","type":"journal-article","created":{"date-parts":[[2005,2,25]],"date-time":"2005-02-25T18:49:18Z","timestamp":1109357358000},"page":"562-567","source":"Crossref","is-referenced-by-count":35,"title":["Management of Extremity Recurrences After Complete Responses to Isolated Limb Perfusion in Patients With Melanoma"],"prefix":"10.1007","volume":"6","author":[{"given":"Andrew L.","family":"Feldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"H. Richard","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L.","family":"Fraker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven K.","family":"Libutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"562_CR1","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00000658-195810000-00009","volume":"148","author":"O Creech","year":"1958","unstructured":"Creech O, Krementz ET, Ryan RF, Winblad JN, et al. Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg 1958;148:616\u201332","journal-title":"Ann Surg"},{"key":"562_CR2","first-page":"305","volume":"129","author":"JS Stehlin","year":"1969","unstructured":"Stehlin JS, et al. Hyperthermic perfusion with chemotherapy for cancers of the extremities. Surg Gynecol Obstet 1969;129:305\u20138","journal-title":"Surg Gynecol Obstet"},{"key":"562_CR3","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/(SICI)1098-2388(199611\/12)12:6<416::AID-SSU7>3.0.CO;2-D","volume":"12","author":"HR Alexander","year":"1996","unstructured":"Alexander HR, Fraker DL, Bartlett DL, et al. Isolated limb perfusion for malignant melanoma. Semin Surg Oncol 1996;12:416\u201328","journal-title":"Semin Surg Oncol"},{"key":"562_CR4","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/(SICI)1097-0142(19971201)80:11<2084::AID-CNCR7>3.0.CO;2-X","volume":"80","author":"DL Bartlett","year":"1997","unstructured":"Bartlett DL, Ma G, Alexander HR, Libutti SK, Fraker DL, et al. Isolated limb reperfusion with tumor necrosis factor and Melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics. Cancer 1997;80:2084\u201390","journal-title":"Cancer"},{"key":"562_CR5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/(SICI)1098-2388(199804\/05)14:3<202::AID-SSU3>3.0.CO;2-C","volume":"14","author":"D Lie\u2019nard","year":"1998","unstructured":"Lie\u2019nard D, Eggermont AM, Kroon BBR, Koops HW, Lejeune FJ, et al. Isolated limb perfusion in primary and recurrent melanoma: indications and results. Semin Surg Oncol 1998;14:202\u20139","journal-title":"Semin Surg Oncol"},{"key":"562_CR6","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/0959-8049(96)00170-0","volume":"32A","author":"MK Lingam","year":"1996","unstructured":"Lingam MK, Byrne DS, Airchison T, MacKie RM, McKay AJ, et al. A single centre\u2019s 10 year experience with isolated limb perfusion in the treatment of recurrent malignant melanoma of the limb. Eur J Cancer 1996;32A:1668\u201373.","journal-title":"Eur J Cancer"},{"key":"562_CR7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archsurg.1997.01430320105017","volume":"132","author":"JF Thompson","year":"1997","unstructured":"Thompson JF, Hunt JA, Shannon KF, Kam PC, et al. Frequency and duration of remission after isolated limb perfusion for melanoma. Arch Surg 1997;132:903\u20137","journal-title":"Arch Surg"},{"key":"562_CR8","first-page":"33","volume":"143","author":"JA Hansson","year":"1977","unstructured":"Hansson JA, Simert G, Vang J, et al. The effect of regional perfusion treatment on recurrent melanoma of the extremities. Acta Chir Scand 1977;143:33\u20139","journal-title":"Acta Chir Scand"},{"key":"562_CR9","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/BF00801607","volume":"22","author":"WC Barker","year":"1995","unstructured":"Barker WC, Andrich MP, Alexander HR, et al. Continuous intraoperative external monitoring of perfusate leak using I-131 human serum albumin during isolated perfusion of the liver and limbs. Eur J Nucl Med 1995;22:1242\u20138","journal-title":"Eur J Nucl Med"},{"key":"562_CR10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0002-9610(85)90006-6","volume":"150","author":"FK Storm","year":"1985","unstructured":"Storm FK, Morton DL, et al. Value of therapeutic hyperthermic limb perfusion in advanced recurrent melanoma of the lower extremity. Am J Surg 1985;150:32\u20135","journal-title":"Am J Surg"},{"key":"562_CR11","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1002\/1097-0142(19890615)63:12<2551::AID-CNCR2820631233>3.0.CO;2-7","volume":"63","author":"F di Filippo","year":"1989","unstructured":"di Filippo F, Calabro A, Giannarelli D, et al. Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion. Cancer 1989;63:2551\u201361","journal-title":"Cancer"},{"key":"562_CR12","first-page":"305","volume":"4","author":"BBR Kroon","year":"1992","unstructured":"Kroon BBR, Klaase JM, van de Merwe SA, van Dongen JA, van der Zee J, et al. Results of a double perfusion schedule using high-dose hyperthermia and Melphalan sequentially for recurrent melanoma of the limbs: a pilot study. Reg Cancer Treat 1992;4:305\u20138","journal-title":"Reg Cancer Treat"},{"key":"562_CR13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0959-8049(05)80163-7","volume":"294","author":"FJ Lejeune","year":"1993","unstructured":"Lejeune FJ, Lie\u2019nard D, Leyvraz S, Mirimanoff RO, et al. Regional therapy of melanoma. Eur J Cancer 1993;294:606\u201312","journal-title":"Eur J Cancer"},{"key":"562_CR14","first-page":"39","volume":"115","author":"JM Klaase","year":"1994","unstructured":"Klaase JM, Kroon BBR, van Geel AN, Eggermont AMM, Franklin HR, Hart AAM, et al. Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion using elphalan. Surgery 1994;115:39\u201345","journal-title":"Surgery"},{"key":"562_CR15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ijc.2910500410","volume":"50","author":"EF McClay","year":"1992","unstructured":"McClay EF, Mastrangelo MJ, Berd D, et al. Effective combination chemo\/hormonal therapy for malignant melanoma: experience with three consecutive trials. Int J Cancer 1992;50:553\u20136","journal-title":"Int J Cancer"},{"key":"562_CR16","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1200\/JCO.1996.14.7.2083","volume":"14","author":"JJ Rusthoven","year":"1996","unstructured":"Rusthoven JJ, Quirt KC, Iscoe NA, et al. Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. J Clin Oncol 1996;14:2083\u201390","journal-title":"J Clin Oncol"},{"key":"562_CR17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nm0398-321","volume":"4","author":"SA Rosenberg","year":"1998","unstructured":"Rosenberg SA, Yang JC, Schwartzentruber DJ, et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med 1998;4: 321\u20137.","journal-title":"Nat Med"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10434-999-0562-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10434-999-0562-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10434-999-0562-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10434-999-0562-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T18:00:35Z","timestamp":1581962435000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10434-999-0562-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1999,9]]}},"alternative-id":["562"],"URL":"https:\/\/doi.org\/10.1007\/s10434-999-0562-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,9]]}}}